Pfizer Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending June 29, 2025: 5.07%

Pfizer Inc. Return on Assets (ROA) is 5.07% for the Trailing 12 Months (TTM) ending June 29, 2025, a -529.27% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.
  • Pfizer Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending June 30, 2024 was -1.18%, a -111.10% change year over year.
  • Pfizer Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending July 02, 2023 was 10.64%, a -32.85% change year over year.
  • Pfizer Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending July 03, 2022 was 15.84%, a 101.76% change year over year.
  • Pfizer Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending July 04, 2021 was 7.85%, a -5.62% change year over year.
Key Data
Date Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share Dividend Per Share